|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Pediatric Neuro-Oncology |
Pediatric Oncology Unit (M.M., R.L., F.S., M.P., F.B., G.C., M.C., A.F., M.T., C.M., D.P., F.F.-B.), Radiotherapy and Physics (L.G., E.P.), Pathology (P.C.), and Radiology (D.S.) Departments and Transfusional Service (F.R.), Istituto Nazionale Tumori, Milan; Developmental Neurology (D.R.) and Neurosurgery (C.S.) Units, Istituto Neurologico C. Besta, Milan; Neuropathology Department, Università La Sapienza, Rome (F.G.); Pediatric Department, Policlinico S. Matteo, University of Pavia (F.L., M.Z.); Italy
1 Address correspondence to Maura Massimino, Pediatric Oncology Unit, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy (maura.massimino{at}istitutotumori.mi.it).
Abstract
Childhood malignant gliomas are rare, but their clinical behavior is almost as aggressive as in adults, with resistance to therapy, rapid progression, and not uncommonly, dissemination. Our study protocol incorporated sequential chemotherapy and high-dose thiotepa in the preradiant phase, followed by focal radiotherapy and maintenance with vincristine and lomustine for a total duration of one year. The induction treatment consisted of two courses of cisplatin (30 mg/m2) plus etoposide (150 mg/m2) x 3 days and of vincristine (1.4 mg/m2) plus cyclophosphamide (1.5 g/m2) plus high-dose methotrexate (8 g/m2), followed by high-dose thiotepa (300 mg/m2 x 3 doses), with harvesting of peripheral blood progenitor cells after the first cisplatin/etoposide course. From August 1996 to March 2003, 21 children, 14 females and 7 males, with a median age of 10 years were enrolled, 18 presenting with residual disease after surgery. Histologies were glioblastoma multiforme in 10, anaplastic astrocytoma in nine, and anaplastic oligodendroglioma in two; sites of origin were supratentorial areas in 17, spine in two, and posterior fossa in two. Of the 21 patients, 12 have died (10 after relapse, with a median time to progression for the whole series of 14 months; one with intratumoral bleeding at 40 months after diagnosis; and one affected by Turcot syndrome for duodenal cancer relapse). Four of 12 relapsed children had tumor dissemination. At a median follow-up of 57 months, overall survival and progression-free survival at four years were 43% and 46%, respectively. Sequential and high-dose chemotherapy can be afforded in front-line therapy of childhood alignant glioma without excessive morbidity and rather encouraging results.
References
Ahmed, T., Feldman, E., Helson, L., Biguzzi, S., and Szalyga, A. (1990) Phase 1-2 trial of high dose thiotepa (HDT) with autologous bone marrow transplantation (ABMT) and localized radiotherapy (RT) for patients (pts) with astrocytoma III-IV. Proc. Am. Assoc. Cancer Res. 31,172 (abstract).
Al-Mefty, O., Al-Rodhan, N.R., Phillips, R.L., el-Senossi, M., and Fox, J.L. (1987) Factors affecting survival of children with malignant gliomas. Neurosurgery 20,416 -420.[Medline]
Bahuau, M., Vidaud, D., Kujas, M., Palangie, A., Assouline, B., Chaignaud-Lebreton, M., Prieur, M., Vidaud, M., Harpey, J.P., Lafourcade, J., and Caille, B. (1997) Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: An original syndrome of tumour proneness. Ann. Genet. 40, 78-91.[ISI][Medline]
Balmaceda, C., Fetell, M.R., and Hesdorffer, C. (1997) Thiotepa and etoposide treatment of recurrent malignant gliomas: Phase I study. Cancer Chemother. Pharmacol. 40, 72-74.[Medline]
Bertolone, S.J., Baum, E.S., Krivit, W., and Hammond, G.D. (1989) A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Children's Cancer Study Group. J. Neurooncol. 7,5 -11.[CrossRef][Medline]
Bouffet, E., Mottolese, C., Jouvet, A., Philip, I., Frappaz, D., Carrie, C., and Brunat-Mentigny, M. (1997) Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. Eur. J. Cancer 33, 91-95.
Busca, A., Miniero, R., Besenzon, L., Cordero di Montezemolo, L., Cenni, M., Fagioli, F., Sandri, A., Vassallo, E., Ricardi, U., and Madon, E. (1997) Etoposide-containing regimens with autologous bone marrow trans-plantation in children with malignant brain tumors. Childs Nerv. Syst. 13,572 -577.[Medline]
Doz, F., Neuenschwander, S., Bouffet, E., Gentet, J.C., Schneider, P., Kalifa, C., Mechinaud, F., Chastagner, P., De Lumley, L., Sariban, E., Plantaz, D., Mosseri, V., Bours, D., Alapetite, C., Zucker, J.M. (2002) Carbo-platin before and during radiation therapy for the treatment of malignant brain stem tumours: A study by the Société Française d'Oncologie Pédiatrique. Eur. J. Cancer 38,815 -819.
Duffner, P.K., Horowitz, M.E., Krischer, J.P., Friedman, H.S.,
Burger, P.C., Cohen, M.E., Sanford, R.A., Mulhern, R.K., James, H.E., Freeman,
C.R., Seidel, F.G., and Kun, L.E. (1993) Postoperative
chemotherapy and delayed radiation in children less than three years of age
with malignant brain tumors. N. Engl. J. Med.
328,1725
-1731.
Finlay, J.L. (1996) The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant. 18(suppl 3), S1-S5.
Finlay, J.L., and Wisoff, J.H. (1999) The impact of extent of resection in the management of malignant gliomas of childhood. Childs Nerv. Syst. 15,786 -788.[Medline]
Finlay, J.L., Boyett, J.M., Yates, A.J., Wisoff, J.H., Milstein,
J.M., Geyer, J.R., Bertolone, S.J., McGuire, P., Cherlow, J.M., Tefft, M.,
Turski, P.A., Wara, W.M., Edwards, M., Sutton, L.N., Berger, M.S., Epstein,
F., Ayers, G., Allen, J.C., and Packer, R.J. (1995) Randomized
phase III trial in childhood high-grade astrocytoma comparing vincristine,
lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's
Cancer Group. J. Clin. Oncol.
13,112
-123.
Finlay, J.L., Goldman, S., Wong, M.C., Cairo, M., Garvin, J., August, C., Cohen, B.H., Stanley, P., Zimmerman, R.A., Bostrom, B., Geyer, J.R., Harris, R.E., Sanders, J., Yates, A.J., Boyett, J.M., and Packer, R.J. (1996) Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. Children's Cancer Group. J. Clin. Oncol. 14,2495 -2503.[Abstract]
Finlay, J.L., Gardner, S., Moreno, S., Bayer, L., Dunkel, I., Johnson, J., Pet-riccione, M., and Halpern, S. (1997) Sequential high-dose thiotepaa with autologous stem cell rescue (ASCR) in patients with primary CNS tumors. J. Neurooncol. 35 (suppl. 1), S16 (abstract 46).
Gnekow, A.K. (1995) Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. Med. Pediatr. Oncol. 24,104 -108.[Medline]
Grovas, A.C., Boyett, J.M., Lindsley, K., Rosenblum, M., Yates, A.J., and Finlay, J.L. (1999) Regimen-related toxicity of myeloablative chemo-therapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multi-forme: Report from the Children's Cancer Group. Med. Pediatr. Oncol. 33,83 -87.[CrossRef][ISI][Medline]
Gururangan, S., Dunkel, I.J., Goldman, S., Garvin, J.H., Rosenblum, M., Boyett, J.M., Gardner, S., Merchant, T.E., Gollamudi, S., and Finlay, J.L. (1998) Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J. Clin. Oncol. 16,2486 -2493.[Abstract]
Hamilton, S.R., Liu, B., Parsons, R.E., Papadopoulos, N., Jen, J.,
Powell, S.M., Krush, A.J., Berk, T., Cohen, Z., Tetu, B., Burger, P.C., Wood,
P.A., Taqi, F., Booker, S.V., Petersen, G.M., Offerhaus, G.J.A., Tersmette,
A.C., Giardiello, F.M., Vogelstein, B., and Kinzler, K.W. (1995)
The molecular basis of Turcot's syndrome. N. Engl. J.
Med. 332,839
-847.
Heideman, R.L., Cole, D.E., Balis, F., Sato, J., Reaman, G.H.,
Packer, R.J., Singher, L.J., Ettinger, L.J., Gillespie, A., Sam, J., and
Poplack, D.G. (1989) Phase I and pharmacokinetic evaluation of
thiotepa in the cere-brospinal fluid and plasma of pediatric patients:
Evidence for dose-dependent plasma clearance of thiotepa. Cancer
Res. 49,736
-741.
Heideman, R.L., Douglass, E.C., Krance, R.A., Fontanesi, J.,
Langston, J.A., Sanford, R.A., Kovnar, E.H., Ochs, J., Kuttesch, J., Jenkins,
J.J., Fairclough, D.L., and Kun, L.E. (1993) High-dose
chemotherapy and autologous bone marrow rescue followed by interstitial and
external-beam radiotherapy in newly diagnosed pediatric malignant gliomas.
J. Clin. Oncol. 11,1458
-1465.
Hisada, M., Garber, J.E., Fung, C.Y., Fraumeni, J.F., Jr., and Li,
F.P. (1998) Multiple primary cancers in families with Li-Fraumeni
syndrome. J. Natl. Cancer Inst.
90,606
-611.
Jakacki, R.I., Jamison, C., Heifetz, S.A., Caldemeyer, K., Hanna, M., and Sender, L. (1997) Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies. Med. Pediatr. Oncol. 29,553 -559.[CrossRef][Medline]
Jakacki, R.I., Jamison, C., Mathews, V.P., Heilman, D.K., Dropcho, E., Cor-netta, K., Macdonald, D.R., and Williams, D.A. (1998) Dose-intensifi-cation of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Med. Pediatr. Oncol. 31,483 -490.[Medline]
Kalifa, C., Hartmann, O., Demeocq, F., Vassal, G., Couanet, D., Terrier-Lacombe, M.J., Valteau, D., Brugieres, L., and Lemerle, J. (1992) High-dose busulfan and thiotepa with autologous bone marrow trans-plantation in childhood malignant brain tumors: A phase II study. Bone Marrow Transplant. 9, 227-233.[Medline]
Kaplan, E.L., and Meier, P. (1958) Non parametric estimation from incom-plete observation. J. Am. Stat. Assoc. 53,457 -481.[CrossRef][ISI]
Kedar, A., Maria, B.L., Graham-Pole, J., Ringdahl, D.M., Quisling, R.G., Mickle, J.P., Mendenhall, N.P., Marcus, R.B., Jr., and Gross, S. (1994) High-dose chemotherapy with marrow reinfusion and hyperfraction-ated irradiation for children with high-risk brain tumors. Med. Pediatr. Oncol. 23,428 -436.[ISI][Medline]
Kreth, F.W., Berlis, A., Spiropoulou, V., Faist, M., Scheremet, R., Rossner, R., Volk, B., and Ostertag, C.B. (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86,2117 -2123.[Medline]
Kuhl, J., Muller, H.L., Berthold, F., Kortmann, R.D., Deinlein, F., Maass, E., Graf, N., Gnekow, A., Scheurlen, W., Gobel, U., Wolff, J.E., Bamberg, M., Kaatsch, P., Kleihues, P., Rating, D., Sorensen, N., and Wiestler, O.D. (1998) Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the German pilot trial HIT'88/'89. Klin. Padiatr. 210,227 -233.[Medline]
Longee, D.C., Friedman, H.S., Albright, R.E., Jr., Burger, P.C., Oakes, W.J., Moore, J.O., and Schold, S.C., Jr. (1990) Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J. Neurosurg. 72,583 -588.[Medline]
Marchese, M.J., and Chang, C.H. (1990) Malignant astrocytic gliomas in children. Cancer 65,2771 -2778.[CrossRef][ISI][Medline]
Mason, W.P., Grovas, A., Halpern, S., Dunkel, I.J., Garvin, J.,
Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D.,
Lindsley, K., Merchant, T.E., O'Malley, B., Bayer, L., Petriccione, M.M.,
Allen, J., and Finlay, J.L. (1998) Intensive chemotherapy and
bone marrow rescue for young children with newly diagnosed malignant brain
tumors. J. Clin. Oncol.
16,210
-221.
Massimino, M., Gandola, L., Casanova, M., Cefalo, G., Ferrari, A., Luksch, R., Riganti, G., and Lombardi, F. (2000a) Concomitant chemoradiotherapy for childhood poor-prognosis gliomas. Med. Pediatr. Oncol. 34,147 -150.[Medline]
Massimino, M., Gandola, L., Cefalo, G., Lasio, G., Riva, D., Fossati-Bellani, F., Gianni, M.C., Luksch, R., Tesoro-Tess, J.D., and Lombardi, F. (2000b) Management of medulloblastoma and ependymoma in infants: A single-institution long-term retrospective report. Childs Nerv. Syst. 16,15 -20.[CrossRef][ISI][Medline]
McCowage, G.B., Friedman, H.S., Moghrabi, A., Kerby, T., Ferrell, L., Stewart, E., Duncan-Brown, M., Fuchs, H.E., Tien, R., McLendon, R.E., Meier, L., Kurtzberg, J., Ashley, D., Colvin, O.M., and Longee, D.C. (1998) Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med. Pediatr. Oncol. 30, 75-80.[Medline]
Packer, R.J., Yates, A., and Sposto, R. Re-evaluation of outcome in children with high-grade gliomas treated on a Children's Cancer Group Study CCG-943: A randomized study of radiation alone versus radiation plus adjuvant CCNU, prednisone and vincristine chemotherapy. 7th International Symposium: Pediatric Neuro-Oncology, May 15-18,1996 , Washington, D.C. (abstract).
Papadakis, V., Dunkel, I.J., Cramer, L.D., Kramer, E., Papadopoulos, E., Goldman, S., Packer, R.J., Willoughby, M., Baker, D., Garvin, J., Strandjord, S., Coccia, P., Kaplan, A.M., Klemperer, M., and Finlay, J.L. (2000) High d h-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant. 26,153 -160.[CrossRef][Medline]
Papadopoulos, K.P., Garvin, J.H., Fetell, M., Vahdat, L.T., Garrett, T.J., Savage, D.G., Balmaceda, C., Bruce, J., Sisti, M., Isaacson, S., DeLa Paz, R., Hawks, R., Bagiella, E., Antman, K.H., and Hesdorffer, C.S. (1998) High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplant. 22,661 -667.[Medline]
Pendergrass, T.W., Milstein, J.M., Geyer, J.R., Mulne, A.F.,
Kosnik, E.J., Morris, J.D., Heideman, R.L., Ruymann, F.B., Stuntz, J.T., and
Bleyer, W.A. (1987) Eight-drugs-in-one-day chemotherapy for brain
tumors: Experience in 107 children and rationale for pre-radiation
chemother-apy. J. Clin. Oncol.
5,1221
-1231.
Peto, R., and Peto, J. (1972) Asymptomatically efficient rank invariant test procedures. J. R. Stat. Soc. Ser. A 135,185 -207.[CrossRef]
Pollack, I.F., Finkelstein, S.D., Woods, J., Burnham, J., Holmes,
E.J., Hamilton, R.L., Yates, A.J., Boyett, J.M., Finlay, J.L., and Sposto, R.
Children's Cancer Group (2002) Expression of p53 and prognosis in
children with malignant gliomas. N. Engl. J. Med.
346,420
-427.
Poppenborg, H., Munstermann, G., Knupfer, M.M., Hotfilder, M., and Wolff, J.E. (1997) C6 cells cross-resistant to cisplatin and radiation. Anticancer Res. 17,2073 -2077.[Medline]
Sposto, R., Ertel, I.J., Jenkin, R.D., Boesel, C.P., Venes, J.L., Ortega, J.A., Evans, A.E., Wara, W., and Hammond, D. (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial. A report from the Children's Cancer Study Group. J. Neurooncol. 7, 165-177.[CrossRef][Medline]
Terzis, A.J., Fiskerstrand, T., Refsum, H., Ueland, P.M., Arnold, H., and Bjerkvig, R. (1993) Proliferation, migration and invasion of human gli-oma cells exposed to antifolate drugs. Int. J. Cancer 54,112 -118.[ISI][Medline]
Wisoff, J.H., Boyett, J.M., Berger, M.S., Brant, C., Li, H., Yates, A.J., McGuire-Cullen, P., Turski, P.A., Sutton, L.N., Allen, J.C., Packer, R.J., and Finlay, J.L. (1998) Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: A report of the Children's Cancer Group trial no. CCG-945. J. Neurosurg. 89, 52-59.[ISI][Medline]
Wolff, J.E., Gnekow, A.K., Kortmann, R.D., Pietsch, T., Urban, C., Graf, N., and Kuhl, J. (2002a) Pre-radiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94,264 -271.[CrossRef][Medline]
Wolff, J.E., Wagner, S., Sindichakis, M., Pietsch, T., Gnekow, A., Kortmann, R.D., Strater, R., and Kuehl, J. (2002b) Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: A phase I study. Anticancer Res. 22,3569 -3572.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
